The term «Meige’s syndrome» or «Breughel’s syndrome» is used by specialists for the description of blepharospasm with the involuntary movements in the lower part of the face and/or masseter muscle. These eponyms «Meige’s syndrome» and «Breughel’s syndrome» make some mess in the terminology. The term «segmental craniocervical dystonia» joins different blepharospam-plus phenotypes and reflects contemporary perceptions about its genetic and pathophysiological community. Botulinotherapy is in fact the only way of symptomathic treatment of craniocervical dystonias.